Corcept Therapeutics Inc (CORT)
28.62
-0.18
(-0.62%)
USD |
NASDAQ |
May 22, 16:00
28.64
+0.02
(+0.07%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow: 124.84M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 124.84M |
December 31, 2023 | 126.90M |
September 30, 2023 | 154.37M |
June 30, 2023 | 134.80M |
March 31, 2023 | 110.63M |
December 31, 2022 | 119.91M |
September 30, 2022 | 135.92M |
June 30, 2022 | 151.16M |
March 31, 2022 | 177.36M |
December 31, 2021 | 167.42M |
September 30, 2021 | 152.70M |
June 30, 2021 | 133.88M |
March 31, 2021 | 142.80M |
December 31, 2020 | 150.73M |
September 30, 2020 | 164.41M |
June 30, 2020 | 172.83M |
March 31, 2020 | 144.83M |
December 31, 2019 | 135.03M |
September 30, 2019 | 108.12M |
June 30, 2019 | 114.44M |
March 31, 2019 | 104.44M |
December 31, 2018 | 115.37M |
September 30, 2018 | 118.82M |
June 30, 2018 | 85.20M |
March 31, 2018 | 85.42M |
Date | Value |
---|---|
December 31, 2017 | 60.52M |
September 30, 2017 | 40.16M |
June 30, 2017 | 38.16M |
March 31, 2017 | 24.37M |
December 31, 2016 | 18.20M |
September 30, 2016 | 17.88M |
June 30, 2016 | 9.921M |
March 31, 2016 | 8.199M |
December 31, 2015 | 3.113M |
September 30, 2015 | -2.47M |
June 30, 2015 | -9.298M |
March 31, 2015 | -18.19M |
December 31, 2014 | -27.55M |
September 30, 2014 | -33.85M |
June 30, 2014 | -36.58M |
March 31, 2014 | -36.78M |
December 31, 2013 | -37.18M |
September 30, 2013 | -38.28M |
June 30, 2013 | -38.89M |
March 31, 2013 | -37.58M |
December 31, 2012 | -36.17M |
September 30, 2012 | -33.66M |
June 30, 2012 | -30.99M |
March 31, 2012 | -30.27M |
December 31, 2011 | -27.40M |
Free Cash Flow Range, Past 5 Years
108.12M
Minimum
Sep 2019
177.36M
Maximum
Mar 2022
141.15M
Average
139.36M
Median
Free Cash Flow Benchmarks
Catalyst Pharmaceuticals Inc | 81.59M |
Regeneron Pharmaceuticals Inc | 3.930B |
United Therapeutics Corp | 752.40M |
Ligand Pharmaceuticals Inc | -19.62M |
NovaBay Pharmaceuticals Inc | -4.524M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 23.76M |
Cash from Investing (Quarterly) | -9.014M |
Cash from Financing (Quarterly) | -0.543M |
Free Cash Flow Per Share (Quarterly) | 0.2161 |
Free Cash Flow to Equity (Quarterly) | 23.76M |
Free Cash Flow to Firm (Quarterly) | 23.76M |
Free Cash Flow Yield | 3.95% |